Therefore, we further investigated whether the synergistic reduction of cAMP level by the combinations of IFN-α and inhibitors of TPL2-MEK-PDE4D pathway have effects on the proliferation of bladder cancer cells. This evidence concerns the gene MAP3K8 and urinary bladder cancer.